We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+9.72%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$16.2B
AUM Growth
+$1.16B
(+7.7%)
Cap. Flow
-$70.2M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
13.75%
Holding
668
New
158
Increased
115
Reduced
144
Closed
223
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$255M |
| 2 |
Broadcom
AVGO
|
+$180M |
| 3 |
AstraZeneca
AZN
|
+$147M |
| 4 |
Intuitive Surgical
ISRG
|
+$142M |
| 5 |
TE Connectivity
TEL
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$441M |
| 2 |
AerCap
AER
|
+$184M |
| 3 |
Western Digital
WDC
|
+$157M |
| 4 |
Akamai
AKAM
|
+$127M |
| 5 |
EPAM Systems
EPAM
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.67% |
| 2 | Consumer Discretionary | 14.19% |
| 3 | Industrials | 13.31% |
| 4 | Healthcare | 12.83% |
| 5 | Financials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Health Catalyst
HCAT
$127M
| $7.41M | 0.05% |
984,560
+100,000
| +11% | +$913K |
|
302
Global E Online
GLBE
$6.91B
| $7.27M | 0.04% |
+200,000
| New | +$7.41M |
|
303
Janux Therapeutics
JANX
$1B
| $7.27M | 0.04% |
193,046
-4,444
| -2% | -$96.8K |
|
304
BBB Foods
TBBB
$4.9B
| $7.13M | 0.04% |
+300,000
| New | +$6.44M |
|
305
GDS Holdings
GDS
$6.29B
| $6.79M | 0.04% |
1,021,690
+745,415
| +270% | +$5.05M |
|
306
Dutch Bros
BROS
$8.96B
| $6.54M | 0.04% |
+198,073
| New | +$5.84M |
|
307
Hamilton Insurance Group
HG
$3.46B
| $6.5M | 0.04% |
466,500
+41,500
| +10% | +$602K |
|
308
Hasbro
HAS
$13.3B
| $6.39M | 0.04% |
+113,070
| New | +$5.75M |
|
309
Unity
U
$19B
| $6.25M | 0.04% |
+234,135
| New | +$7.36M |
|
310
Patterson-UTI
PTEN
$4.19B
| $6.07M | 0.04% |
508,659
-880,852
| -63% | -$9.78M |
|
311
Sonos
SONO
$1.83B
| $6.02M | 0.04% |
+315,928
| New | +$5.6M |
|
312
CALL
Aligos Therapeutics
ALGS
$47.8M
| $5.98M | 0.04% |
244,129
| – | – |
|
313
Sagimet Biosciences
SGMT
$591M
| $5.95M | 0.04% |
1,098,213
+611,653
| +126% | +$4.39M |
|
314
Clearfield
CLFD
$391M
| $5.93M | 0.04% |
192,388
-107,612
| -36% | -$3.08M |
|
|
CIVI
315
DELISTED
Civitas Resources
CIVI
| $5.92M | 0.04% |
78,041
+34,101
| +78% | +$2.28M |
|
316
Option Care Health
OPCH
$3.67B
| $5.87M | 0.04% |
175,000
-710,384
| -80% | -$23M |
|
317
Kimco Realty
KIM
$16.2B
| $5.87M | 0.04% |
+299,113
| New | +$5.95M |
|
318
Nkarta
NKTX
$176M
| $5.81M | 0.04% |
537,580
+86,849
| +19% | +$903K |
|
319
Solid Biosciences
SLDB
$918M
| $5.52M | 0.03% |
414,615
-222,664
| -35% | -$2.08M |
|
|
NXDR
320
Nextdoor Holdings
NXDR
$1.04B
| $5.46M | 0.03% |
2,426,849
+1,476,849
| +155% | +$2.76M |
|
|
URG
321
CALL
Ur-Energy
URG
$564M
| $5.44M | 0.03% |
3,400,000
-1,000,000
| -23% | -$1.66M |
|
322
Insmed
INSM
$29.4B
| $5.43M | 0.03% |
+200,000
| New | +$5.6M |
|
323
Salesforce
CRM
$162B
| $5.42M | 0.03% |
+17,980
| New | +$5.19M |
|
324
McCormick & Company Non-Voting
MKC
$14.3B
| $5.4M | 0.03% |
+70,350
| New | +$4.78M |
|
|
FLG
325
Flagstar Bank National Association
FLG
$5.84B
| $5.25M | 0.03% |
543,654
+168,702
| +45% | +$3.12M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q1 2024 Portfolio in Review
As of Q1 2024, Alyeska Investment Group held 668 positions worth $16.2B, up 7.7% from $15.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Alyeska Investment Group's Q1 2024 filing shows 158 new, 115 increased, 144 reduced and 223 closed positions. Its largest new stake was Alphabet (Google) Class A: 1,783,151 shares worth $269M. The largest sale was Meta Platforms (Facebook), an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Alyeska Investment Group's largest Q1 2024 buy was Alphabet (Google) Class A: 1,783,151 shares worth $269M.
- Alyeska Investment Group added most to AstraZeneca in Q1 2024, an estimated $147M increase.
- Alyeska Investment Group's biggest Q1 2024 reduction was Meta Platforms (Facebook), cutting an estimated $441M.
- Alyeska Investment Group fully exited Akamai in Q1 2024, selling an estimated $127M.
- Alyeska Investment Group's ten largest holdings make up 14% of its $16.2B portfolio in Q1 2024.
- Alyeska Investment Group opened 158 new positions and closed 223 in Q1 2024.
- Alyeska Investment Group's portfolio value rose 7.7% quarter-over-quarter to $16.2B.
Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.